Year: 2017
Type: article
Abstract: Better integration of clinical features with molecular and genomic data may help to establish a more reliable regression grading system that could serve as a future predictor of outcomes for patients with resectable esophageal cancer. See also pages 4106‐13.
Source: Cancer
DOI: 10.1002/cncr.30952
Author: Nabil F. Saba
Institutions: Emory University, Winship Cancer Institute
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2750876392